Search

Your search keyword '"McGuffog L."' showing total 473 results

Search Constraints

Start Over You searched for: Author "McGuffog L." Remove constraint Author: "McGuffog L."
473 results on '"McGuffog L."'

Search Results

1. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

2. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

3. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

4. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

5. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

6. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

7. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

8. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

9. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

10. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

11. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

12. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

13. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

14. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

15. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

16. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

17. Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

18. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.

19. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

20. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

21. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (vol 12, 1078, 2021)

22. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

23. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

24. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

25. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

26. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

27. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

28. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

29. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

30. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

31. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness.

32. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

33. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

34. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer.

35. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

36. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

37. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

38. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

39. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

40. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

41. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

42. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

44. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

45. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

46. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

47. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

48. Shared heritability and functional enrichment across six solid cancers.

49. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4).

50. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

Catalog

Books, media, physical & digital resources